GE HealthCare Technologies (GEHC) Short-Term Debt issuances (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Short-Term Debt issuances came in at -$1.0 million in Q1 2026, down 200.0% YoY from $1.0 million in Q1 2025, and down 200.0% on a QoQ basis from $1.0 million in Q1 2025.
GE HealthCare Technologies (GEHC) Short-Term Debt issuances (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Short-Term Debt issuances data on file, last reported at -$1.0 million in Q1 2026.
- Quarterly Short-Term Debt issuances fell 200.0% year-over-year to -$1.0 million in Q1 2026, while the trailing twelve-month figure through Jun 2025 was $1.0 million (changed N/A YoY) and the FY2025 annual result came in at $1.0 million, changed N/A from the prior year.
- Short-Term Debt issuances eased to -$1.0 million in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Short-Term Debt issuances ranged from a high of $8.0 million in Q3 2022 to a low of -$9.0 million in Q1 2023.
- A 5-year average of -$250000.0 and a median of $0.0 in 2022 frame the typical range for Short-Term Debt issuances.
- Annual changes were most pronounced in 2023 — Short-Term Debt issuances plunged 550.0% — and 2024, when it jumped 111.11%.
- Tracing GEHC's Short-Term Debt issuances over 5 years: stood at $1.0 million in 2022, then plunged by 400.0% to -$3.0 million in 2023, then soared by 66.67% to -$1.0 million in 2024, then surged by 200.0% to $1.0 million in 2025, then slumped by 200.0% to -$1.0 million in 2026.
- The last three Short-Term Debt issuances figures came in at -$1.0 million (Q1 2026), $1.0 million (Q1 2025), and -$1.0 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 64.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -164.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.42 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -47.66 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -37.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | -3.00 Mn |
| Dec 31, 2023 | -3.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Mar 31, 2023 | -9.00 Mn |
| Mar 31, 2023 | -9.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 8.00 Mn |
| Sep 30, 2022 | 8.00 Mn |